Karyopharm Therapeutics (KPTI) Current Leases (2019 - 2025)
Karyopharm Therapeutics (KPTI) reported Current Leases of $969000.0 for Q4 2025, up 121.23% on a YoY basis from $438000.0 in Q4 2024, and up 5.1% quarter-over-quarter from $922000.0 in Q3 2025.
Karyopharm Therapeutics (KPTI) Current Leases (2019 - 2025) Analysis & Trends
Karyopharm Therapeutics has reported Current Leases for 7 years, with the latest figure at $969000.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Leases rose 121.23% year-over-year to $969000.0; the trailing twelve-month figure through Dec 2025 stood at $969000.0 (up 121.23% YoY), and the FY2025 full-year result was $969000.0, up 121.23% from the prior year.
- Current Leases for Q4 2025 stood at $969000.0, up from $922000.0 in the prior quarter.
- The five-year high for Current Leases was $3.7 million in Q3 2024, with the low at $438000.0 in Q4 2024.
- Historically, Current Leases has averaged $2.4 million across 5 years, with a median of $2.5 million in 2022.
- Annual changes were most pronounced in 2024 — Current Leases slumped 86.76% — and 2025, when it soared 121.23%.
- Karyopharm Therapeutics' Current Leases stood at $2.3 million in 2021, then grew by 24.01% to $2.9 million in 2022, then climbed by 15.18% to $3.3 million in 2023, then tumbled by 86.76% to $438000.0 in 2024, then surged by 121.23% to $969000.0 in 2025.
- The last three Current Leases figures came in at $969000.0 (Q4 2025), $922000.0 (Q3 2025), and $1.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Karyopharm Therapeutics | 95.31 Mn | 31.56 Mn | 32.74 Mn | 969,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 969,000.00 |
| Sep 30, 2025 | 922,000.00 |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 927,000.00 |
| Dec 31, 2024 | 438,000.00 |
| Sep 30, 2024 | 3.67 Mn |
| Jun 30, 2024 | 3.55 Mn |
| Mar 31, 2024 | 3.43 Mn |
| Dec 31, 2023 | 3.31 Mn |
| Sep 30, 2023 | 3.20 Mn |
| Jun 30, 2023 | 3.08 Mn |
| Mar 31, 2023 | 2.98 Mn |
| Dec 31, 2022 | 2.87 Mn |
| Sep 30, 2022 | 2.77 Mn |
| Jun 30, 2022 | 2.62 Mn |
| Mar 31, 2022 | 2.46 Mn |
| Dec 31, 2021 | 2.32 Mn |
| Sep 30, 2021 | 2.16 Mn |
| Jun 30, 2021 | 2.08 Mn |
| Mar 31, 2021 | 2.00 Mn |